Estradiol acetate
- Generic Name
- Estradiol acetate
- Brand Names
- Femring
- Drug Type
- Small Molecule
- Chemical Formula
- C20H26O3
- CAS Number
- 4245-41-4
- Unique Ingredient Identifier
- 5R97F5H93P
- Background
Estradiol acetate is a pro-drug ester of Estradiol, a naturally occurring hormone that circulates endogenously within the human body. Estradiol is the most potent form of all mammalian estrogenic steroids and acts as the major female sex hormone. As a pro-drug of estradiol, estradiol acetate therefore has the same downstream effects within the body through b...
- Indication
Femring is indicated for the treatment of vasomotor and urogenital symptoms associated with menopause. Use of Femring (estradiol acetate) has been shown to improve symptoms caused by atrophy of the vagina (such as dryness, burning, pruritus and dyspareunia) and/or the lower urinary tract (urinary urgency and dysuria).
- Associated Conditions
- Moderate Menopausal Vasomotor Symptoms, Moderate menopausal vulvovaginal atrophy, Severe Vasomotor Symptoms Associated With Menopause, Severe menopausal vulvovaginal atrophy
- Associated Therapies
- -
Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.
- Conditions
- Interventions
- First Posted Date
- 2010-02-18
- Last Posted Date
- 2013-04-22
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 249
- Registration Number
- NCT01070979
- Locations
- 🇺🇸
Warner Chilcott Investigational Site, Tacoma, Washington, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.